Clinical Trials Directory

Trials / Completed

CompletedNCT05734989

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Improving Screening and Therapy Provision Among Hispanics/Latinx at Risk for Chronic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
59 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. Additionally, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.

Detailed description

The goals of this study are to (1) Increase rates of screening and monitoring of CKD and CKD risk factors for Hispanic/Latinx community members in Durham by utilizing existing community resources and screening events and (2) Pilot test a PCP-facing intervention to promote guideline concordant testing and evidence-based therapy provision for Hispanics/Latinx with T2D at community health centers, utilizing clinical champions and pharmacists. The investigators anticipate the study will identify patients with CKD or CKD risk factors and establish feasibility of the pilot intervention, which the investigators plan to ultimately apply on a large scale to reduce inequities and improve clinical outcomes among Hispanics/Latinx.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBPBlood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.
DIAGNOSTIC_TESTHbA1cHbA1c will screen to identify patients with Type 2 diabetes
BEHAVIORALPCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKDGuidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.

Timeline

Start date
2023-05-18
Primary completion
2025-04-04
Completion
2025-04-04
First posted
2023-02-21
Last updated
2025-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05734989. Inclusion in this directory is not an endorsement.